Log in
Enquire now
‌

US Patent 11507847 Gene expression programming

Patent 11507847 was granted and assigned to Raytheon on November, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Raytheon
Raytheon
Date Filed
July 25, 2019
Date of Patent
November 22, 2022
Patent Applicant
Raytheon
Raytheon
Patent Application Number
16522235
Patent Citations
‌
US Patent 10521584 Computer threat analysis service
‌
US Patent 10929722 Anomaly detection in streaming networks
‌
US Patent 10937465 Anomaly detection with reduced memory overhead
‌
US Patent 11036858 System and method for training a model for detecting malicious objects on a computer system
‌
US Patent 11132923 Encryption using spatial voting
‌
US Patent 11321462 Device behavior anomaly detection
‌
US Patent 11341235 Anomaly detection with adaptive auto grouping
‌
US Patent 11340603 Behavior monitoring using convolutional data modeling
‌
US Patent 10076273 Real-time monitoring and control of physical and arousal status of individual organisms
‌
US Patent 10110629 Managed honeypot intrusion detection system
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11507847
Patent Primary Examiner
‌
Brandon S Cole
CPC Code
‌
H04W 12/12
‌
G06N 3/126
‌
H04L 63/14
‌
G06F 21/55
‌
G06N 5/041

Find more entities like US Patent 11507847 Gene expression programming

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.